Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed

BACKGROUND: Novel anticoagulations (NOACs) are increasingly prescribed for the prevention of stroke in premenopausal women with atrial fibrillation. Small studies suggest NOACs are associated with a higher risk of abnormal uterine bleeds than vitamin K antagonists (VKAs). Because there is no direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolden, Herbert J. A., Maas, Angela H. E. M., van der Wilt, Gert Jan, Grutters, Janneke P. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640919/
https://www.ncbi.nlm.nih.gov/pubmed/29029621
http://dx.doi.org/10.1186/s12872-017-0692-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640919/
https://www.ncbi.nlm.nih.gov/pubmed/29029621
http://dx.doi.org/10.1186/s12872-017-0692-1

Ejemplares similares